MENU
ACAD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ACADIA Pharmaceuticals (ACAD) Ownership - Who owns ACADIA Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.81B
P/E Ratio
21.63
Total Cash
565.33M
Projected Growth
N/A
Total Debt
49.37M
Revenue
929.24M
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash/Share
3.40
Total Debt/Equity
N/A
Revenue/Share
5.60 USD as % of share price
Fundamentals
ACAD
Capitalization
2.81B
P/E Ratio
21.63
Risk (Beta)
0.70
Dividend Yield
N/A
Total Cash
565M
Total Cash/Share
3.40
Total Debt
49.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.60%
Revenue
929M
ROE
N/A
Book Value
577M
P/B Ratio
4.86
Cash Flow
N/A
Earnings
0.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
16K
Current Ratio
2.29
Current Revenue Per Employee
403872.60
Dividends Per Share - Security
N/A
EBITDA
125M
Float
N/A
Float - Current
N/A
Gross Income Margin
92.47
Revenue To Assets
15.97
Shares Held By Institutions
4.99B
Shares Outstanding - Current
166M
Total Liabilities
400M
Total Volume MTD
N/A
Value
-1
Gain YTD
-46.119
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceuticals drugs for treatment of central nervous system disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
12830 El Camino Real
Phone
+1 858 558-2871
Employees
598
Web
https://www.acadia.com